Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Operations and Comprehensive Loss (Unaudited)

v3.20.2
Condensed Consolidated Statements of Operations and Comprehensive Loss (Unaudited) - USD ($)
3 Months Ended 6 Months Ended
Jun. 30, 2020
Jun. 30, 2019
Jun. 30, 2020
Jun. 30, 2019
Income Statement [Abstract]        
Revenues
Expenses:        
Research and development 6,109,000 16,307,000 12,927,000 28,044,000
General and administrative 5,538,000 5,612,000 11,950,000 11,271,000
Depreciation and amortization 834,000 2,057,000 2,899,000 3,715,000
Licensed technology impairment charge 32,916,000
Total expenses 12,481,000 23,976,000 60,692,000 43,030,000
Loss from operations (12,481,000) (23,976,000) (60,692,000) (43,030,000)
Interest and miscellaneous income 271,000 52,000 923,000 551,000
Interest expense (800,000) (1,400,000)
Net loss $ (13,010,000) $ (23,924,000) $ (61,169,000) $ (42,479,000)
Basic and diluted loss per common share $ (0.14) $ (0.49) $ (0.66) $ (0.88)
Weighted average number of common shares outstanding – basic and diluted 93,180,837 48,961,988 92,910,014 48,458,004
Other comprehensive income/(loss):        
Change in unrealized (losses) gains related to  available-for-sale debt securities $ (253,000) $ 133,000
Comprehensive loss $ (13,263,000) $ (23,924,000) $ (61,036,000) $ (42,479,000)